The Sudeep Pharma IPO opened to an active start, with early subscription numbers setting the tone for the day. While the broader stock market today moved in its usual rhythm, the focus stayed firmly on this public issue as investors tracked category-wise demand closely.
Market Performance Snapshot
The overall market sentiment remained steady, but the buzz centred on the opening day of the Sudeep Pharma IPO. Early participation from non-institutional and retail categories added momentum to the maiden issue.
Sudeep Pharma IPO: Day 1 Subscription Highlights
The IPO opened for bidding on September 21, drawing meaningful participation in the first half of the day. By 12:30 pm, subscription data reflected solid traction across categories.
By mid-day, the IPO had been subscribed to 67 per cent against the total offer size of nearly 1.06 crore shares. The bids crossed 70.44 lakh shares, showing early interest from multiple investor segments.
Key Day 1 numbers:
- Total subscription: 67 per cent
- Bids received: More than 70.44 lakh shares.
- Total offer size: Nearly 1.06 crore shares
- Non-Institutional Investors subscription: 131 per cent
- Retail subscription: 77 per cent
- QIB portion: Minimal bidding so far
Strong demand from non-institutional bidders stood out, with the category fully subscribed ahead of others.
About the Sudeep Pharma IPO
Sudeep Pharma operates in the pharmaceutical, food, nutrition, and speciality ingredients space. The company has launched an IPO consisting of a fresh issue and an offer-for-sale, with a total size of ₹895 crore.
IPO Structure:
- Total issue size: ₹895 crore
- Fresh issue: ₹95 crore
- Offer-for-sale (OFS): 1.3 crore shares worth ₹800 crore
- Price band: ₹563 to ₹593 per share
The issue will remain open from November 21 to November 25.
For retail investors:
- Minimum lot size: 25 shares
- Minimum investment at upper price band: ₹14,825
Important dates:
- Allotment date: Likely November 26
- Listing date: Scheduled for November 28
Use of proceeds from fresh issue:
- ₹75.81 crore allocated to capital expenditure
- Primarily for machinery procurement for the production line at Nandesari Facility 1 in Gujarat
- The remaining portion will go toward general corporate purposes.
Company Details
Sudeep Pharma follows a technology-driven manufacturing approach, producing excipients and speciality ingredients for the pharmaceutical, food, and nutrition sectors. Its product portfolio is broad and diversified, catering to multiple applications and industry needs.
Summary
The Sudeep Pharma IPO saw an active start, with Day 1 subscription reaching 67 per cent by 12:30 pm. More than 70.44 lakh bids came in against the total offer size of nearly 1.06 crore shares. The issue is priced between ₹563 and ₹593 and aims to raise ₹895 crore through a combination of fresh issue and OFS.
The IPO window remains open until November 25, with allotment expected on November 26 and listing scheduled for November 28. The fresh capital will primarily support machinery procurement and capacity expansion at the company's Nandesari Facility.
The opening day numbers place the Sudeep Pharma IPO among the notable highlights in the stock market today, drawing significant attention from investors tracking the pharmaceutical and speciality ingredients sector.
Easy & quick
Leave A Comment?